2025-04-10 - Analysis Report
## Albemarle Corp (ALB) Stock Review

**0) Executive Summary:**

Albemarle Corp (ALB) is a leading global producer of lithium, bromine, and other specialty chemicals.  Recent performance shows significant underperformance compared to the S&P 500 (VOO), with negative CAGR in recent years and concerning financial indicators.  However, the high expected return suggests potential long-term growth, though considerable risk is present.


**1) Performance Comparison:**

Albemarle Corp (ALB) is a global leader in lithium and bromine production, crucial for batteries and other industrial applications.

* **Cumulative Return (ALB):** 3.59%
* **Cumulative Return (VOO):** 66.94%
* **Return Difference (ALB vs VOO):** -63.3%
* **Relative Divergence:** 0.5 (Indicates ALB is performing significantly below VOO,  in the lower 50th percentile of historical divergence from VOO.)

The provided Alpha/Beta analysis reveals significant volatility and inconsistent performance. While some periods show strong positive returns, others show dramatic negative returns, indicating a high-risk, high-reward investment profile.  The consistently low or negative Alpha suggests ALB has not significantly outperformed the market after accounting for risk (Beta).

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 99.0% | 7.7% | 70.0% | 0.0 | 13.7 |
| 2016-2018  | 13.0% | 58.1% | -5.0% | 0.0 | 8.4 |
| 2017-2019  | -45.0% | 58.1% | -74.0% | -0.0 | 8.1 |
| 2018-2020  | 101.0% | 62.9% | 75.0% | 0.7 | 16.6 |
| 2019-2021  | 268.0% | 62.9% | 214.0% | 0.8 | 26.5 |
| 2020-2022  | 239.0% | 75.8% | 233.0% | 1.1 | 24.8 |
| 2021-2023  | -53.0% | 77.6% | -69.0% | 0.6 | 16.6 |
| 2022-2024  | -204.0% | 77.6% | -221.0% | 0.8 | 10.1 |
| 2023-2025  | -344.0% | 77.6% | -359.0% | 2.0 | 7.1 |


**2) Recent Price Movement:**

* **Closing Price:** $60.47
* **5-Day Moving Average:** $58.87
* **20-Day Moving Average:** $71.37
* **60-Day Moving Average:** $78.06

The price is below all three moving averages, suggesting a possible downtrend. The significant one-day price increase of 19.13% from the previous close requires further investigation to determine the cause (e.g., news, market sentiment).

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.5289 (High Risk)
* **RSI:** 28.29 (Oversold territory, suggesting potential upward momentum but also vulnerability to further declines)
* **PPO:** -2.79 (Negative, indicating bearish momentum)
* **Recent Relative Strength Divergence:** 0.5 (+), short-term upward trend.
* **Expected Return:** 14409.3% (This exceptionally high figure needs further justification and clarification. It is unrealistic without further explanation of the methodology.)

The combination of high risk, oversold RSI, negative PPO, and the large price increase raises concerns about volatility and the potential for significant price swings.


**4) Recent Earnings Analysis:**

| Date       | EPS     | Revenue      |
|------------|---------|-------------|
| 2024-11-06 | -9.45   | $1.35 B     |
| 2024-07-31 | -1.96   | $1.43 B     |
| 2024-05-01 | -0.08   | $1.36 B     |
| 2023-11-01 | 2.58    | $2.31 B     |
| 2024-11-06 | 2.58    | $2.31 B     |

The data appears to contain a duplication (2024-11-06).  Excluding this, recent earnings show significant negative EPS, indicating substantial losses, despite relatively consistent revenue. This needs further investigation to understand the causes of these losses.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $1.23B | 11.22% |
| 2024-09-30 | $1.35B | -7.68% |
| 2024-06-30 | $1.43B | -0.74% |
| 2024-03-31 | $1.36B | 2.86% |
| 2023-12-31 | $2.36B | -29.88% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $9.96B | 0.76% |
| 2024-09-30 | $10.24B | -10.44% |
| 2024-06-30 | $11.22B | -1.68% |
| 2024-03-31 | $11.53B | 0.02% |
| 2023-12-31 | $9.41B | -6.56% |

Financial data reveals significant volatility in both revenue and profitability. Negative profit margins and ROE in several quarters are very concerning. The substantial shift in equity over the period also merits further examination.

**6) Overall Analysis:**

ALB's performance is highly volatile, underperforming the S&P 500 significantly.  While the high expected return hints at potential long-term growth, the substantial negative EPS, negative profit margins, and high-risk indicators raise serious concerns. The recent large price increase needs explanation.  Further investigation into the causes of the negative earnings and the justification for the exceptionally high expected return are crucial before any investment decision.  The current data suggests ALB is a high-risk investment with potential for substantial losses.  A thorough due diligence, including analysis of industry trends and company-specific factors, is strongly recommended before any investment.
